IFNAR1 and cancer: Chen et al. [12] showed that depletion of type I IFN receptor, IFNAR1, in cancer cells promoted a strong immune response after treatment with radiation, indicating that the outcome of type I IFN signalling in tumour progression might be dependent on several factors, including in which compartment of the tumour this pathway is activated.